RESUMEN
RATIONALE AND OBJECTIVES: To determine if deliberative practice with novel ultrasound guidance targeting tasks improves simulated procedural skill. MATERIALS AND METHODS: In a nonrandomized interventional trial first year medical students practiced the previous described dowel and straw targeting tasks 1 hour a week for 4 weeks (training group) or had no training (controls). Afterward, they each performed a simulated amniocentesis (AMN) and chorionic villus sampling (CVS) procedure. Procedures were scored using a global rating scale (GRS) and compared between groups with Mann-Whitney U tests. Two-way random effects intraclass correlation coefficients for the inter- and intra-rater variability were calculated for each item in both GRS's. RESULTS: The training group (nâ¯=â¯22) had higher scores on several aspects and overall performance of AMN compared to controls (nâ¯=â¯15). There were no differences between groups for CVS. The inter-rater and intra-rater reliability of the GRS's for both AMN and CVS ranged from 0.16 to 0.89 with most values demonstrating good to excellent agreement. CONCLUSION: This study demonstrates validity evidence in the content and internal structure domains for the AMN and CVS simulators and their accompanying GRS's. Repetitive practice of the targeting tasks improved student performance in simulated AMN, but modifications are needed for it to be relevant to other procedures such as CVS.
Asunto(s)
Amniocentesis , Muestra de la Vellosidad Coriónica , Amniocentesis/normas , Muestra de la Vellosidad Coriónica/normas , Educación Médica/métodos , Femenino , Humanos , Embarazo , Reproducibilidad de los Resultados , Estudiantes de Medicina , Ultrasonografía/métodos , Ultrasonografía/normasRESUMEN
High-throughput sequencing of fetal DNA is a promising and increasingly common method for the discovery of all (or all coding) genetic variants in the fetus, either as part of prenatal screening or diagnosis, or for genetic diagnosis of spontaneous abortions. In many cases, the fetal DNA (from chorionic villi, amniotic fluid, or abortive tissue) can be contaminated with maternal cells, resulting in the mixture of fetal and maternal DNA. This maternal cell contamination (MCC) undermines the assumption, made by traditional variant callers, that each allele in a heterozygous site is covered, on average, by 50% of the reads, and therefore can lead to erroneous genotype calls. We present a panel of methods for reducing the genotyping error in the presence of MCC. All methods start with the output of GATK HaplotypeCaller on the sequencing data for the (contaminated) fetal sample and both of its parents, and additionally rely on information about the MCC fraction (which itself is readily estimated from the high-throughput sequencing data). The first of these methods uses a Bayesian probabilistic model to correct the fetal genotype calls produced by MCC-unaware HaplotypeCaller. The other two methods "learn" the genotype-correction model from examples. We use simulated contaminated fetal data to train and test the models. Using the test sets, we show that all three methods lead to substantially improved accuracy when compared with the original MCC-unaware HaplotypeCaller calls. We then apply the best-performing method to three chorionic villus samples from spontaneously terminated pregnancies.
Asunto(s)
Muestra de la Vellosidad Coriónica/métodos , Contaminación de ADN , Pruebas Genéticas/métodos , Análisis de Secuencia de ADN/métodos , Adulto , Teorema de Bayes , Muestra de la Vellosidad Coriónica/normas , Femenino , Pruebas Genéticas/normas , Humanos , Aprendizaje Automático , Mutación , Embarazo , Análisis de Secuencia de ADN/normas , Relación Señal-RuidoAsunto(s)
Aborto Espontáneo/epidemiología , Amniocentesis/normas , Muestra de la Vellosidad Coriónica/normas , Amniocentesis/métodos , Muestra de la Vellosidad Coriónica/métodos , Femenino , Humanos , Metaanálisis como Asunto , Estudios Observacionales como Asunto , Embarazo , Ensayos Clínicos Controlados Aleatorios como Asunto , Medición de Riesgo , Clase SocialRESUMEN
BACKGROUND: During pregnancy, fetal cells suitable for genetic testing can be obtained from amniotic fluid by amniocentesis (AC), placental tissue by chorionic villus sampling (CVS), or fetal blood. A major disadvantage of second trimester amniocentesis is that the results are available relatively late in pregnancy (after 16 weeks' gestation). Earlier alternatives are chorionic villus sampling (CVS) and early amniocentesis, which can be performed in the first trimester of pregnancy. OBJECTIVES: The objective of this review was to compare the safety and accuracy of all types of AC (i.e. early and late) and CVS (e.g. transabdominal, transcervical) for prenatal diagnosis. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (3 March 2017), ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform (ICTRP; 3 March 2017), and reference lists of retrieved studies. SELECTION CRITERIA: All randomised trials comparing AC and CVS by either transabdominal or transcervical route. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. The quality of the evidence was assessed using the GRADE approach. MAIN RESULTS: We included a total of 16 randomised studies, with a total of 33,555 women, 14 of which were deemed to be at low risk of bias. The number of women included in the trials ranged from 223 to 4606.Studies were categorized into six comparisons: 1. second trimester AC versus control; 2. early versus second trimester AC; 3. CVS versus second trimester AC; 4. CVS methods; 5. Early AC versus CVS; and 6. AC with or without ultrasound.One study compared second trimester AC with no AC (control) in a low risk population (women = 4606). Background pregnancy loss was around 2%. Second trimester AC compared to no testing increased total pregnancy loss by another 1%. The confidence intervals (CI) around this excess risk were relatively large (3.2% versus 2.3 %, average risk ratio (RR) 1.41, 95% CI 0.99 to 2.00; moderate-quality evidence). In the same study, spontaneous miscarriages were also higher (2.1% versus 1.3%; average RR 1.60, 95% CI 1.02 to 2.52; high-quality evidence). The number of congenital anomalies was similar in both groups (2.0% versus 2.2%, average RR 0.93, 95% CI 0.62 to 1.39; moderate-quality evidence).One study (women = 4334) found that early amniocentesis was not a safe early alternative compared to second trimester amniocentesis because of increased total pregnancy losses (7.6% versus 5.9%; average RR 1.29, 95% CI 1.03 to 1.61; high-quality evidence), spontaneous miscarriages (3.6% versus 2.5%, average RR 1.41, 95% CI 1.00 to 1.98; moderate-quality evidence), and a higher incidence of congential anomalies, including talipes (4.7% versus 2.7%; average RR 1.73, 95% CI 1.26 to 2.38; high-quality evidence).When pregnancy loss after CVS was compared with second trimester AC, there was a clinically significant heterogeneity in the size and direction of the effect depending on the technique used (transabdominal or transcervical), therefore, the results were not pooled. Only one study compared transabdominal CVS with second trimester AC (women = 2234). They found no clear difference between the two procedures in the total pregnancy loss (6.3% versus 7%; average RR 0.90, 95% CI 0.66 to 1.23, low-quality evidence), spontaneous miscarriages (3.0% versus 3.9%; average RR 0.77, 95% CI 0.49 to 1.21; low-quality evidence), and perinatal deaths (0.7% versus 0.6%; average RR 1.18, 95% CI 0.40 to 3.51; low-quality evidence). Transcervical CVS may carry a higher risk of pregnancy loss (14.5% versus 11.5%; average RR 1.40, 95% CI 1.09 to 1.81), but the results were quite heterogeneous.Five studies compared transabdominal and transcervical CVS (women = 7978). There were no clear differences between the two methods in pregnancy losses (average RR 1.16, 95% CI 0.81 to 1.65; very low-quality evidence), spontaneous miscarriages (average RR 1.68, 95% CI 0.79 to 3.58; very low-quality evidence), or anomalies (average RR 0.68, 95% CI 0.41 to 1.12; low-quality evidence). We downgraded the quality of the evidence to low due to heterogeneity between studies. Transcervical CVS may be more technically demanding than transabdominal CVS, with more failures to obtain sample (2.0% versus 1.1%; average RR 1.79, 95% CI 1.13 to 2.82, moderate-quality evidence).Overall, we found low-quality evidence for outcomes when early amniocentesis was compared to transabdominal CVS. Spontaneous miscarriage was the only outcome supported by moderate-quality evidence, resulting in more miscarriages after early AC compared with transabdominal CVS (2.3% versus 1.3%; average RR 1.73, 95% CI 1.15 to 2.60). There were no clear differences in pregnancy losses (average RR 1.15, 95% CI 0.86 to 1.54; low-quality evidence), or anomalies (average RR 1.14, 95% CI 0.57 to 2.30; very low-quality evidence).We found one study that examined AC with or without ultrasound, which evaluated a type of ultrasound-assisted procedure that is now considered obsolete. AUTHORS' CONCLUSIONS: Second trimester amniocentesis increased the risk of pregnancy loss, but it was not possible to quantify this increase precisely from only one study, carried out more than 30 years ago.Early amniocentesis was not as safe as second trimester amniocentesis, illustrated by increased pregnancy loss and congenital anomalies (talipes). Transcervical chorionic villus sampling compared with second trimester amniocentesis may be associated with a higher risk of pregnancy loss, but results were quite heterogeneous.Diagnostic accuracy of different methods could not be assessed adequately because of incomplete karyotype data in most studies.
Asunto(s)
Amniocentesis/efectos adversos , Muestra de la Vellosidad Coriónica/efectos adversos , Amniocentesis/normas , Muestra de la Vellosidad Coriónica/normas , Anomalías Congénitas/diagnóstico , Femenino , Humanos , Embarazo , Primer Trimestre del Embarazo , Segundo Trimestre del Embarazo , Ensayos Clínicos Controlados Aleatorios como AsuntoAsunto(s)
Amniocentesis/normas , Muestra de la Vellosidad Coriónica/normas , Competencia Clínica , Obstetricia/educación , Diagnóstico Prenatal/normas , Trisomía/diagnóstico , Aborto Espontáneo/epidemiología , Amniocentesis/tendencias , Muestra de la Vellosidad Coriónica/tendencias , ADN/sangre , Femenino , Humanos , Obstetricia/normas , Embarazo , Diagnóstico Prenatal/tendenciasAsunto(s)
Amniocentesis/métodos , Amniocentesis/normas , Muestra de la Vellosidad Coriónica/métodos , Muestra de la Vellosidad Coriónica/normas , Programas Nacionales de Salud , Diagnóstico Prenatal/métodos , Diagnóstico Prenatal/normas , Ultrasonografía Prenatal/métodos , Ultrasonografía Prenatal/normas , Amniocentesis/efectos adversos , Muestra de la Vellosidad Coriónica/efectos adversos , Femenino , Alemania , Humanos , Recién Nacido , Consentimiento Informado , Educación del Paciente como Asunto , Embarazo , Diagnóstico Prenatal/efectos adversos , Factores de Riesgo , Ultrasonografía Prenatal/efectos adversosRESUMEN
OBJECTIVES: The goal of this study is to evaluate the success of a training program in chorionic villus sampling (CVS) of early pregnancy failure (EPF) for maternal-fetal medicine (MFM) fellows. METHODS: We conducted a retrospective review of a new training program in CVS for MFM fellows. Women with EPF up to 13 weeks estimated gestational age were offered inclusion in our program and counseled on alternatives. Transcervical CVS was performed for both fellow education and cytogenetic diagnosis. The primary outcome was a successful diagnosis, and the secondary outcome was cell growth by fellow experience. RESULTS: Thirty-nine patients diagnosed with EPF from December 2011 to March 2013 underwent CVS. Villi obtained via CVS yielded a diagnosis in 62% of cases. CVS samples with successful karyotype had more villi but were otherwise similar. CVS by experience showed a trend towards increased success and villi volume after the first five procedures. Abnormal results were obtained in 72% of cases, 15% of which led to changes in care. CONCLUSION: CVS of EPF is an option for the training of MFM fellows as it was acceptable to most patients, and the majority of CVS specimens yielded a karyotype diagnosis.
Asunto(s)
Muestra de la Vellosidad Coriónica , Educación Médica/métodos , Pérdida del Embrión/diagnóstico , Adulto , Muestra de la Vellosidad Coriónica/normas , Muestra de la Vellosidad Coriónica/estadística & datos numéricos , Competencia Clínica/estadística & datos numéricos , Análisis Citogenético , Pérdida del Embrión/patología , Femenino , Edad Gestacional , Humanos , Embarazo , Primer Trimestre del Embarazo , Diagnóstico Prenatal/métodos , Estudios Retrospectivos , Adulto JovenRESUMEN
OBJECTIVE: To assess the frequency and significance of maternal cell contamination (MCC) in the invasive prenatal diagnosis, and to analysis the MCC effect on prenatal diagnosis results. METHODS: Totally 519 amniotic fluid samples from second trimester pregnancy, 57 chorionic villus samples from first trimester pregnancy, and 576 blood samples from corresponded pregnant women were collected and genotyped by Promega PowerPlex 16 system. MCC was determined according to the genotyping results. Karyotypic and molecular diagnosis results were contrasted between MCC and non-MCC specimen of the same fetal. RESULTS: MCC presented in 3.1% (16/519) uncultured amniotic fluid, 1.3% (7/519) cultured amniotic fluid and 5% (3/57) villi specimens. In the study of fetal karyotype, MCC had no significant effect on normal female fetus; but for male fetus and abnormal female fetus, there were risk of erroneous results of mosaics. As to molecular diagnosis, MCC resulted in more complex effects for the different diagnostic methods. And 10%MCC had led to misdiagnosis. CONCLUSIONS: For the prenatal cytogenetic tests, MCC should be excluded when there were mosaicism karyotype results or suspicious MCC of chorionic villi samples. The effects of MCC had more seriously impact on prenatal molecular testing, which suggesting the recommend regular identity test for MCC should be carried out.
Asunto(s)
Líquido Amniótico/citología , Artefactos , Errores Diagnósticos/prevención & control , Diagnóstico Prenatal/métodos , Manejo de Especímenes/métodos , Adulto , Amniocentesis/métodos , Amniocentesis/normas , Líquido Amniótico/química , Células Cultivadas , Muestra de la Vellosidad Coriónica/métodos , Muestra de la Vellosidad Coriónica/normas , ADN/análisis , Contaminación de ADN , Femenino , Humanos , Cariotipificación , Masculino , Técnicas de Diagnóstico Molecular , Reacción en Cadena de la Polimerasa/métodos , Embarazo , Diagnóstico Prenatal/normas , Manejo de Especímenes/normas , Secuencias Repetidas en TándemAsunto(s)
Aneuploidia , Síndrome de Down/diagnóstico , Educación de Postgrado en Medicina/métodos , Obstetricia/educación , Diagnóstico Prenatal/normas , Muestra de la Vellosidad Coriónica/normas , Diagnóstico Precoz , Femenino , Humanos , Capacitación en Servicio , Embarazo , Primer Trimestre del Embarazo , Medición de Riesgo/métodosRESUMEN
OBJECTIVE: To characterize the indications of pregnant women who sought the Fetal Medicine Services of the Hospital das Clínicas, at the Medical School of the Universidade de São Paulo for performing invasive diagnostic procedures, and to evaluate the results of fetal karyotypes and their pregnancies. METHODS: A retrospective and observational study on pregnant women who underwent chorionic villus sampling (CVS), amniocentesis, and cordocentesis in the period from February, 2005 to December, 2009. Other diagnostic or therapeutic procedures were not included. The result of pregnancy was obtained by consulting patient electronic records, medical records, and/or telephone call. RESULTS: 713 procedures were performed (113 CVS, 340 amniocenteses, and 260 cordocenteses). The main indication for performing invasive procedures was the presence of structural changes in fetuses, followed by increased values of nuchal translucency, and advanced maternal age. Fetal karyotype was altered in 186 cases (26.1%). The 18 trisomy was the commonest aneuploidy followed by the 21 trisomy, X monosomy, and 13 trisomy. There were 4.9% cases of miscarriage, 25.7% cases of stillborn infants, and 13% cases of neonatal deaths. Eight pregnant women opted for legally induced abortion. 99% of pregnant women whose fetuses did not present abnormalities and presented normal fetal karyotype had infants who were born alive.
Asunto(s)
Enfermedades Fetales/diagnóstico , Enfermedades Fetales/genética , Feto/anomalías , Cariotipificación/métodos , Diagnóstico Prenatal/métodos , Adolescente , Adulto , Amniocentesis/normas , Muestra de la Vellosidad Coriónica/normas , Cordocentesis/normas , Femenino , Edad Gestacional , Humanos , Edad Materna , Persona de Mediana Edad , Embarazo , Estudios Retrospectivos , Mortinato , Adulto JovenRESUMEN
OBJETIVO: Caracterizar as indicações das gestantes que procuraram o serviço de Medicina Fetal do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo para realização de procedimentos invasivos diagnósticos e avaliar os resultados dos cariótipos fetais e de suas gestações. MÉTODOS: Estudo observacional retrospectivo das gestantes que realizaram biópsia de vilo corial (BVC), amniocentese e cordocentese no período de fevereiro de 2005 a dezembro de 2009. Não foram incluídos outros procedimentos diagnósticos ou procedimentos terapêuticos. O resultado da gestação foi obtido através de consulta de prontuário eletrônico e/ou físico e/ou contato telefônico. RESULTADOS: Foram realizados 713 procedimentos (113 BVC, 340 amniocenteses e 260 cordocenteses). A principal indicação para a realização dos procedimentos invasivos foi a presença de alterações estruturais nos fetos, seguido por valores aumentados da translucência nucal e pela idade materna avançada. O cariótipo fetal esteve alterado em 186 casos (26,1%). A trissomia do cromossomo 18 foi a aneuploidia mais comum, seguida pela trissomia do 21, a monossomia do X e a trissomia do cromossomo 13. Ocorreram 4,9% de abortamento, 25,7% de natimortos e 13% de neomortos. Oito gestantes optaram pela interrupção judicial, e 99% das gestantes cujos fetos não apresentavam malformação e que apresentavam cariótipo fetal normal tiveram nativivos.
OBJECTIVE: To characterize the indications of pregnant women who sought the Fetal Medicine Services of the Hospital das Clínicas, at the Medical School of the Universidade de São Paulo for performing invasive diagnostic procedures, and to evaluate the results of fetal karyotypes and their pregnancies. METHODS: A retrospective and observational study on pregnant women who underwent chorionic villus sampling (CVS), amniocentesis, and cordocentesis in the period from February, 2005 to December, 2009. Other diagnostic or therapeutic procedures were not included. The result of pregnancy was obtained by consulting patient electronic records, medical records, and/or telephone call. RESULTS: 713 procedures were performed (113 CVS, 340 amniocenteses, and 260 cordocenteses). The main indication for performing invasive procedures was the presence of structural changes in fetuses, followed by increased values of nuchal translucency, and advanced maternal age. Fetal karyotype was altered in 186 cases (26.1%). The 18 trisomy was the commonest aneuploidy followed by the 21 trisomy, X monosomy, and 13 trisomy. There were 4.9% cases of miscarriage, 25.7% cases of stillborn infants, and 13% cases of neonatal deaths. Eight pregnant women opted for legally induced abortion. 99% of pregnant women whose fetuses did not present abnormalities and presented normal fetal karyotype had infants who were born alive.
Asunto(s)
Adolescente , Adulto , Femenino , Humanos , Persona de Mediana Edad , Embarazo , Adulto Joven , Enfermedades Fetales/diagnóstico , Enfermedades Fetales/genética , Feto/anomalías , Cariotipificación/métodos , Diagnóstico Prenatal/métodos , Amniocentesis/normas , Muestra de la Vellosidad Coriónica/normas , Cordocentesis/normas , Edad Gestacional , Edad Materna , Estudios Retrospectivos , MortinatoAsunto(s)
Aneuploidia , Muestra de la Vellosidad Coriónica , Cariotipificación/métodos , Reacción en Cadena de la Polimerasa/métodos , Diagnóstico Prenatal/métodos , Células Cultivadas , Muestra de la Vellosidad Coriónica/normas , Muestra de la Vellosidad Coriónica/estadística & datos numéricos , Auditoría Clínica/estadística & datos numéricos , Errores Diagnósticos/estadística & datos numéricos , Femenino , Pruebas Genéticas/normas , Pruebas Genéticas/estadística & datos numéricos , Humanos , Cariotipificación/normas , Cariotipificación/estadística & datos numéricos , Aprendizaje , Reacción en Cadena de la Polimerasa/normas , Reacción en Cadena de la Polimerasa/estadística & datos numéricos , Guías de Práctica Clínica como Asunto , Embarazo , Diagnóstico Prenatal/estadística & datos numéricos , Reproducibilidad de los Resultados , Reino Unido/epidemiologíaRESUMEN
OBJECTIVES: According to new recommendations, a high combined risk for Down syndrome in the first trimester of pregnancy must indicate the need for a prenatal diagnosis. This is possible thanks to chorionic villous sampling. The objective of our study was to show that chorionic villous sampling is achievable in everyday practice, even outside research centers for pre-natal diagnosis. PATIENTS AND METHODS: It was a descriptive, retrospective study. All the patients who underwent a chorionic villous sampling in our level II maternity center from November 2005 to September 2009 were included. Success and complications rates linked with the procedure were calculated. RESULTS: One hundred and fourteen pregnancies were included. A definitive diagnosis was given in 98.25% of cases. A secondary amniocentesis was necessary in 1.75% of cases. A medical termination of the pregnancy was done in 18.42% of cases. Without accounting for underlying pathology, fetal loss rate was up to 5.75%. Only one case of unexpected fetal loss was noted (1.15% of the ongoing pregnancies). CONCLUSION: Our study shows that the presence of trained professional allows for onsite performance chorionic villous sampling.
Asunto(s)
Muestra de la Vellosidad Coriónica , Síndrome de Down/diagnóstico , Adulto , Muestra de la Vellosidad Coriónica/normas , Estudios de Factibilidad , Femenino , Instituciones de Salud , Humanos , Embarazo , Estudios RetrospectivosRESUMEN
OBJECTIVE: The objective was to determine the risk of sampling error in amniocentesis and chorionic villus sampling (CVS) in singleton and multiple pregnancies. Data from this and other published studies were used to discuss current practice guidelines for molecular identity testing. METHOD: Clinical and laboratory records of all patients undergoing molecular-based identity testing in our clinical laboratory from July 2002 until March 2008 were reviewed. DNA microsatellite testing was performed to determine zygosity in multiple pregnancies and maternal cell contamination (MCC) in both singleton and multiple pregnancies. RESULTS: MCC was detected in 6/148 (4%) CVS and 1/87 (1%) amniotic fluids from singleton pregnancies. In two of the CVS, only maternal cells were found. In 2/24 (8%) twin pregnancies, the same fetus was tested twice. In a total of 285 pregnancies (235 singleton, 24 twin, 26 with >or= 3 fetuses), without molecular identity testing, four women would have received erroneous results. CONCLUSION: Current guidelines recommend molecular identity testing for MCC in conjunction with molecular diagnostic testing, but not for cytogenetic testing. No published guidelines were found for zygosity testing in multiple pregnancies. We suggest that identity testing be considered for all prenatal testing of multiple pregnancies, especially if CVS is performed.
Asunto(s)
Amniocentesis/métodos , Muestra de la Vellosidad Coriónica/métodos , ADN/genética , Repeticiones de Microsatélite , Patología Molecular/métodos , Amniocentesis/normas , Muestra de la Vellosidad Coriónica/normas , ADN/química , Femenino , Humanos , Patología Molecular/normas , Embarazo , Embarazo Múltiple , Estudios Retrospectivos , Sesgo de SelecciónAsunto(s)
Amniocentesis/normas , Muestra de la Vellosidad Coriónica/normas , Competencia Clínica/normas , Aborto Espontáneo/prevención & control , Amniocentesis/estadística & datos numéricos , Muestra de la Vellosidad Coriónica/estadística & datos numéricos , Femenino , Humanos , Guías de Práctica Clínica como Asunto , EmbarazoRESUMEN
OBJECTIVES: Guidelines exist for amniocentesis and chorionic villous sampling (CVS) practice, but there is no consensus regarding individual techniques. Our survey sought to review current practice within specialist centres in the United Kingdom. METHODS: RCOG sub-specialist training centres were invited to complete a postal questionnaire, seeking their consultants' primary choices for amniocentesis and CVS techniques. Information sought included needle choice, local anaesthetic (LA), suction methods, quantity of samples obtained; and with regard to CVS, preferred approach [transcervical (TC) or transabdominal (TA)]. RESULTS: Response rate was 96% providing information on 111 consultants (111 amniocentesis/90 CVS). During amniocentesis, 86% use 22G needles and 70% are helped by an assistant who aspirates a set liquor volume (69%). For CVS, 98% use a TA approach, 89% use LA, and 29% an 18G single needle with 38% preferring a 17/19G double needle but no clear consensus regarding the use of assistants. CONCLUSIONS: There is some agreement among specialists in the United Kingdom regarding techniques for invasive prenatal diagnosis. For amniocentesis, most operators use 22G needles, with an assistant to aspirate a set volume of fluid regardless of gestation. For CVS, there is considerable variation in needle choice, although most operators use a TA approach with LA.
Asunto(s)
Amniocentesis/métodos , Muestra de la Vellosidad Coriónica/métodos , Amniocentesis/normas , Muestra de la Vellosidad Coriónica/normas , Femenino , Humanos , Embarazo , Encuestas y Cuestionarios , Reino UnidoRESUMEN
OBJECTIVES: To report our experience over the past 10 years of chorionic villi sampling (CVS) prenatal diagnosis in a high-risk population for chromosomal anomalies, and to analyze, according to the results, the advantages and disadvantages of using quantitative fluorescence polymerase chain reaction (QF-PCR) in amniotic fluid with respect to a conventional semi-direct cytogenetic CVS method in a retrospective theoretical review. METHODS: We performed 3,868 cytogenetic analyses from CVS using a semi-direct culture method in a selected high-risk population for chromosomal abnormalities and we compare our findings with the theoretical results obtained using QF-PCR on amniotic fluid. RESULTS: The rate of chromosomal anomalies detected with the semi-direct CVS cytogenetic study, excluding confined placental mosaicism (CPM), was 6.8%. 26.3% of all them would be missed by using QF-PCR only and among them, 21.4% of cases would represent a severe adverse obstetric outcome. CONCLUSIONS: We think that semi-direct CVS cytogenetic analysis in comparison with QF-PCR in amniotic fluid is similarly rapid, performed earlier and more complete, allowing the chromosomal diagnosis in the first trimester of gestation. We propose the use of QF-PCR as an additional method to semi-direct CVS analysis in order to avoid false-negative results, as a rapid alternative to long-term culture.
Asunto(s)
Muestra de la Vellosidad Coriónica/métodos , Aberraciones Cromosómicas , Asesoramiento Genético/métodos , Diagnóstico Prenatal/métodos , Adulto , Muestra de la Vellosidad Coriónica/normas , Trastornos de los Cromosomas/diagnóstico , Trastornos de los Cromosomas/genética , Femenino , Asesoramiento Genético/normas , Humanos , Embarazo , Diagnóstico Prenatal/normas , Estudios RetrospectivosRESUMEN
Prenatal diagnosis of fetal chromosomal abnormalities is the most common indication for invasive prenatal testing. The prevalence of chromosomal abnormalities in clinically recognized early pregnancy loss is greater than 50%(1). Fetuses with aneuploidy account for 6-11% of all still births and neonatal deaths(2). Chromosomal abnormalities that are compatible with life but cause considerable morbidity occur in 0.65% of newborns, and structural chromosomal rearrangements that will eventually affect reproduction occur in 0.2% of newborns(3). Consequently, screening and diagnostic programs to detect the most common autosomal trisomies in liveborn infants, including Down syndrome, are well established. The purpose of this document is to provide clinical management guidelines for the prenatal diagnosis of these aneuploidies.